FGF8 and osteoarthritis: In a monoiodoacetic acid‐induced osteoarthritis model, anti‐FGF‐8 antibodies reduced ECM release to the synovium, suggesting that the FGF‐8 may promote the degradation of ECM and damage cartilage structure in osteoarthritis (Figure 4).91, 92